Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes

Ingo Janssen, Clara C. Chen, Zhenping Zhuang, Corina M. Millo, Katherine I. Wolf, Alexander Ling, Frank I. Lin, Karen T. Adams, Peter Herscovitch, Richard A. Feelders, Antonio T. Fojo, David Taieb, Electron Kebebew and Karel Pacak
Journal of Nuclear Medicine August 2017, 58 (8) 1236-1242; DOI: https://doi.org/10.2967/jnumed.116.187690
Ingo Janssen
1Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
2Department of Radiology and Nuclear Medicine, Section of Nuclear Medicine, University Hospital Schleswig Holstein, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clara C. Chen
3Nuclear Medicine Division, Radiology & Imaging Sciences, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhenping Zhuang
4Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corina M. Millo
5Positron Emission Tomography Department, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine I. Wolf
1Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Ling
6Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank I. Lin
7Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen T. Adams
1Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Herscovitch
5Positron Emission Tomography Department, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A. Feelders
8Division of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio T. Fojo
9Endocrine Oncology Branch, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Taieb
10Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Electron Kebebew
11Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karel Pacak
1Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 8 1236-1242
DOI 
https://doi.org/10.2967/jnumed.116.187690
PubMed 
28336782

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication November 23, 2016
  • Accepted for publication February 10, 2017
  • Published online August 1, 2017.

Article Versions

  • previous version (March 23, 2017 - 04:43).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Ingo Janssen1,2,
  2. Clara C. Chen3,
  3. Zhenping Zhuang4,
  4. Corina M. Millo5,
  5. Katherine I. Wolf1,
  6. Alexander Ling6,
  7. Frank I. Lin7,
  8. Karen T. Adams1,
  9. Peter Herscovitch5,
  10. Richard A. Feelders8,
  11. Antonio T. Fojo9,
  12. David Taieb10,
  13. Electron Kebebew11 and
  14. Karel Pacak1
  1. 1Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
  2. 2Department of Radiology and Nuclear Medicine, Section of Nuclear Medicine, University Hospital Schleswig Holstein, Lübeck, Germany
  3. 3Nuclear Medicine Division, Radiology & Imaging Sciences, National Institutes of Health, Bethesda, Maryland
  4. 4Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
  5. 5Positron Emission Tomography Department, National Institutes of Health, Bethesda, Maryland
  6. 6Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland
  7. 7Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
  8. 8Division of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
  9. 9Endocrine Oncology Branch, National Cancer Institute, Bethesda, Maryland
  10. 10Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France; and
  11. 11Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
  1. For correspondence or reprints contact: Karel Pacak, National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Rm. 1E-3140, 10 Center Dr. MSC-1109, Bethesda, MD 20892. E-mail: karel{at}mail.nih.gov
View Full Text

Statistics from Altmetric.com

Cited By...

  • 31 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
    Jacques W.M. Lenders, Michiel N. Kerstens, Laurence Amar, Aleksander Prejbisz, Mercedes Robledo, David Taieb, Karel Pacak, Joakim Crona, Tomáš Zelinka, Massimo Mannelli, Timo Deutschbein, Henri J.L.M. Timmers, Frederic Castinetti, Henning Dralle, Jřri Widimský, Anne-Paule Gimenez-Roqueplo, Graeme Eisenhofer
    Journal of Hypertension 2020 38 8
  • European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
    David Taïeb, Rodney J. Hicks, Elif Hindié, Benjamin A. Guillet, Anca Avram, Pietro Ghedini, Henri J. Timmers, Aaron T. Scott, Saeed Elojeimy, Domenico Rubello, Irène J. Virgolini, Stefano Fanti, Sona Balogova, Neeta Pandit-Taskar, Karel Pacak
    European Journal of Nuclear Medicine and Molecular Imaging 2019 46 10
  • Personalized Management of Pheochromocytoma and Paraganglioma
    Svenja Nölting, Nicole Bechmann, David Taieb, Felix Beuschlein, Martin Fassnacht, Matthias Kroiss, Graeme Eisenhofer, Ashley Grossman, Karel Pacak
    Endocrine Reviews 2022 43 2
  • Performance of 68Ga-DOTA–Conjugated Somatostatin Receptor–Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis
    Sangwon Han, Chong Hyun Suh, Sungmin Woo, Yeon Joo Kim, Jong Jin Lee
    Journal of Nuclear Medicine 2019 60 3
  • Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
    Svenja Nölting, Martin Ullrich, Jens Pietzsch, Christian G. Ziegler, Graeme Eisenhofer, Ashley Grossman, Karel Pacak
    Cancers 2019 11 10
  • The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma
    Lauren Fishbein, Jaydira Del Rivero, Tobias Else, James R. Howe, Sylvia L. Asa, Debbie L. Cohen, Patricia L.M. Dahia, Douglas L. Fraker, Karyn A. Goodman, Thomas A. Hope, Pamela L. Kunz, Kimberly Perez, Nancy D. Perrier, Daniel A. Pryma, Mabel Ryder, Aaron R. Sasson, Michael C. Soulen, Camilo Jimenez
    Pancreas 2021 50 4
  • Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
    Rami Alrezk, Andres Suarez, Isabel Tena, Karel Pacak
    Frontiers in Endocrinology 2018 9
  • Head and Neck Paragangliomas: An Update on the Molecular Classification, State-of-the-Art Imaging, and Management Recommendations
    Edward P. Lin, Bennett B. Chin, Lauren Fishbein, Toshio Moritani, Simone P. Montoya, Shehanaz Ellika, Shawn Newlands
    Radiology: Imaging Cancer 2022 4 3
  • Molecular imaging and therapy of somatostatin receptor positive tumors
    Jana Ivanidze, Michelle Roytman, Arielle Sasson, Myrto Skafida, Thomas J. Fahey, Joseph R. Osborne, Silvina P. Dutruel
    Clinical Imaging 2019 56
  • 18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma
    David Taïeb, Abhishek Jha, Carole Guerin, Ying Pang, Karen T Adams, Clara C Chen, Pauline Romanet, Philippe Roche, Wassim Essamet, Alexander Ling, Martha M Quezado, Frédéric Castinetti, Fréderic Sebag, Karel Pacak
    The Journal of Clinical Endocrinology & Metabolism 2018 103 4

Article usage

Article usage: March 2017 to April 2025

AbstractFullPdf
Mar 2017201020
Apr 2017184013
May 201792020
Jun 201739022
Jul 20173305
Aug 201711961859
Sep 2017208713
Oct 2017179818
Nov 201710167
Dec 201777210
Jan 20185866
Feb 2018411015
Mar 201837120
Apr 20184379
May 20183234
Jun 20182357
Jul 20182733
Aug 20183454
Sep 201829139
Oct 201818136
Nov 201818107
Dec 20181445
Jan 201930812
Feb 201918810
Mar 201923515
Apr 201930415
May 201936812
Jun 201928812
Jul 201935715
Aug 2019341013
Sep 201926912
Oct 201922716
Nov 20192716
Dec 201925311
Jan 202026512
Feb 202024924
Mar 2020324137
Apr 2020223120
May 2020205187
Jun 2020306127
Jul 202013286
Aug 2020205117
Sep 2020381145
Oct 2020274164
Nov 2020204168
Dec 2020251660
Jan 202115178
Feb 2021142421
Mar 20217265
Apr 202181313
May 2021102714
Jun 2021141814
Jul 2021111919
Aug 2021141610
Sep 202110197
Oct 2021151728
Nov 2021222125
Dec 2021172816
Jan 20222910
Feb 202220122
Mar 2022441111
Apr 20229128
May 202211911
Jun 202291414
Jul 202221234
Aug 202217106
Sep 2022141815
Oct 202212116
Nov 202232114
Dec 20225112
Jan 20234229
Feb 2023295
Mar 202362112
Apr 2023375
May 20231118
Jun 2023190
Jul 202321111
Aug 202351410
Sep 20232113
Oct 20234812
Nov 202312610
Dec 20235285
Jan 202451410
Feb 20243199
Mar 202421623
Apr 202434515
May 202403616
Jun 202422310
Jul 202462817
Aug 202454216
Sep 202442813
Oct 202472613
Nov 20245188
Dec 20241167
Jan 202541915
Feb 202567283
Mar 202543415
Apr 202585123
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (8)
Journal of Nuclear Medicine
Vol. 58, Issue 8
August 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
Ingo Janssen, Clara C. Chen, Zhenping Zhuang, Corina M. Millo, Katherine I. Wolf, Alexander Ling, Frank I. Lin, Karen T. Adams, Peter Herscovitch, Richard A. Feelders, Antonio T. Fojo, David Taieb, Electron Kebebew, Karel Pacak
Journal of Nuclear Medicine Aug 2017, 58 (8) 1236-1242; DOI: 10.2967/jnumed.116.187690

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
Ingo Janssen, Clara C. Chen, Zhenping Zhuang, Corina M. Millo, Katherine I. Wolf, Alexander Ling, Frank I. Lin, Karen T. Adams, Peter Herscovitch, Richard A. Feelders, Antonio T. Fojo, David Taieb, Electron Kebebew, Karel Pacak
Journal of Nuclear Medicine Aug 2017, 58 (8) 1236-1242; DOI: 10.2967/jnumed.116.187690
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Performance of 68Ga-DOTA-Conjugated Somatostatin Receptor-Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis
  • Advances in adrenal tumors 2018
  • Google Scholar

More in this TOC Section

Oncology

  • Quantitative assessment of radiation therapy-induced cardiovascular complications with FDG-PET and NaF-PET imaging in lung cancer and other thoracic malignancies
  • Redifferentiation and/or Enhancement of Radioiodine Uptake for 131I Therapy: A Review of the Literature
  • The evolving role of FAPI-PET in assessing patients with various malignancies and its potential superiority over FDG-PET in this setting
Show more Oncology

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • 18F-FDOPA
  • 18F-FDA
  • pheochromocytoma
  • paraganglioma
  • polycythemia
SNMMI

© 2025 SNMMI

Powered by HighWire